Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A BURGER

Showing results (11-20 of 1,155) with videos related to

Pageof 116
Sort By:
Blood|January 9, 2016
Obinutuzumab: the more the merrier?Jan A Burger
Blood|April 12, 2012
BRAF mutation: supporting diversity in HCLJan A Burger
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2011
Antiangiogenic agents should be integrated into the standard treatment for patients with ovarian cancerR A Burger
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2019
Going through Changes: Surface IgM Levels during CLL Therapy with IbrutinibJan A Burger
Expert Opinion on Medical Diagnostics|March 14, 2013
The times they are a-changin': prognostic markers in the new era of BCR-targeting therapies for CLLJan A Burger
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2007
Experience with bevacizumab in the management of epithelial ovarian cancerRobert A Burger
Current Hematologic Malignancy Reports|November 23, 2011
Inhibiting B-cell receptor signaling pathways in chronic lymphocytic leukemiaJan A Burger
Advances in Experimental Medicine and Biology|September 10, 2013
The CLL cell microenvironmentJan A Burger
Current Opinion in Oncology|September 11, 2012
Targeting the microenvironment in chronic lymphocytic leukemia is changing the therapeutic landscapeJan A Burger
Cancer Journal (Sudbury, Mass.)|August 16, 2021
Integrating New Therapies for Chronic Lymphocytic LeukemiaJan A Burger
Pageof 116

Showing results (11-20 of 1,155) with videos related to

Sort By:
Pageof 116
Blood|January 9, 2016
Obinutuzumab: the more the merrier?Jan A Burger
Blood|April 12, 2012
BRAF mutation: supporting diversity in HCLJan A Burger
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2011
Antiangiogenic agents should be integrated into the standard treatment for patients with ovarian cancerR A Burger
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2019
Going through Changes: Surface IgM Levels during CLL Therapy with IbrutinibJan A Burger
Expert Opinion on Medical Diagnostics|March 14, 2013
The times they are a-changin': prognostic markers in the new era of BCR-targeting therapies for CLLJan A Burger
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2007
Experience with bevacizumab in the management of epithelial ovarian cancerRobert A Burger
Current Hematologic Malignancy Reports|November 23, 2011
Inhibiting B-cell receptor signaling pathways in chronic lymphocytic leukemiaJan A Burger
Advances in Experimental Medicine and Biology|September 10, 2013
The CLL cell microenvironmentJan A Burger
Current Opinion in Oncology|September 11, 2012
Targeting the microenvironment in chronic lymphocytic leukemia is changing the therapeutic landscapeJan A Burger
Cancer Journal (Sudbury, Mass.)|August 16, 2021
Integrating New Therapies for Chronic Lymphocytic LeukemiaJan A Burger
Pageof 116